CoChat

Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges

Shih, Ie-Ming, Kurman, Robert J. · 2005 · Clinical Cancer Research

The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.

Abstract

Ovarian borderline (low malignant potential) tumors are a puzzling group of neoplasms that do not fall neatly into benign or malignant categories. Their behavior is enigmatic, their pathogenesis unclear, and their clinical management controversial, especially for serous borderline tumors (SBT), the most common type of ovarian borderline tumor. Clarifying the nature of borderline tumors and their relationship to invasive carcinoma has puzzled investigators since the category was created over 30 years ago. Much of the confusion and controversy concerning these tumors is due to a lack of understanding of their pathogenesis and an absence of a model for the development of ovarian carcinoma. This review summarizes recent molecular studies of ovarian borderline tumors with special emphasis on the role of SBT in tumor progression and its relationship to ovarian serous carcinoma.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-05-0755

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 79 references

Research works printed but not linked: 2

  1. Scully RE. World Health Organization international histological classification of tumours. 2nd ed. New York (NY): Springer; 1999.
  2. Ichikawa Y, Nishida M, Suzuki H. Mutation of KRAS protooncogene is associated iwth histological subtypes in human mucinous ovarian tumors. Cancer Res 1994;54:33–5.

Cited by

See all 142

Metadata

Authors
Shih, I.-M., & Kurman, R. J.
Affiliations
Johns Hopkins University (US)
Venue
Clinical Cancer Research
Published
2005-10-15
Volume
11
Issue
20
Pages
7273-7279
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2145474139
Cited by
142
References
80
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 4 · 2017: 3 · 2016: 9 · 2015: 4 · 2014: 3 · 2013: 12 · 2012: 6
FWCI
1.80
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA103937)
Topics
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords
borderline ovarian tumors, low malignant potential, serous borderline tumor, serous ovarian cancer, tumor progression, molecular pathogenesis, invasive carcinoma
MeSH terms
Female, Humans, Models, Biological, Mutation, Ovarian Neoplasms, Gene Expression Regulation, Neoplastic, Cystadenoma, Serous, Disease Progression, Proto-Oncogene Proteins c-raf, Proto-Oncogene Proteins B-raf

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-05-0755
The paper
Shih, I.-M., & Kurman, R. J. (2005). Molecular Pathogenesis of Ovarian Borderline Tumors: New Insights and Old Challenges. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-05-0755

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.